Longtime Pharmaceutical Co., Ltd., previously known as Nanhai Longtime Pharmaceutical, is founded in 2003 engaged in R&D, production and sales of genetically engineered medicine. Located in the Nanhai Park, Foshan National High-tech Zone, the company is now having totally 6500m2 of workshop, lab and warehouse that meet the GMP standard and producing 13.5 million doses annually. Through years of efforts, Longtime has been successively identified as a demonstration base for national high-tech industrialization, Guangdong high-tech enterprise, Guangdong BFGF R&D engineering and technological research center, as well as Guangdong postdoctoral innovation practice base.
“Gaifu” (recombinant human basic fibroblast growth factor for external use), Longtime’s leading product, is a national-level new medicine (Category I) and one of the nine genetically-engineered medicines that have proprietary intellectual property rights in China. Moreover, it has been listed in various national key plans and awarded lots of prizes. Gaifu’s world-leading technology and unprecedented wound-healing way, which changes “passive repair” into “active repair”, can not only accelerate healing mechanism and greatly shorten healing time, but also prevent scars and fix impaired physical functions. Given its velocity and quality of healing wounds, it is widely applied in many relevant areas like trauma, empyrosis, surgery and facelift. Currently, our sales network has been across the country, while Gaifu has been utilized in over 1300 hospitals as regular medicine and highly recognized by medical workers as well as patients for its visible therapeutic effect.
Click for more: http://www.langtai.com.cn
